![Kenichi Nagai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 67 927 $ in data 30/06/2026
Kenichi Nagai has held leadership roles at BrightPath Biotherapeutics Co., Ltd. since 2009, serving as President, CEO & Representative Director starting in 2011.
Since 2016, Mr. Nagai has been President & Representative Director at Advanced.
Immunotherapy Co., Ltd. Since 2019, Mr. Nagai has served as Outside Director at KORTUC, Inc. Current jobs include positions at BrightPath Biotherapeutics Co., Ltd., Advanced.
Immunotherapy Co., Ltd., and KORTUC, Inc.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2025 | 240.000 ( 0,17% ) | 67 927 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BRIGHTPATH BIOTHERAPEUTICS CO., LTD. | Amministratore Delegato | 01/03/2011 |
Advanced.Immunotherapy Co., Ltd. | Presidente | 01/12/2016 |
KORTUC, Inc.
 KORTUC, Inc. Medical SpecialtiesHealth Technology Develops sensitizers for radiotherapy | Direttore/Membro del Consiglio | 01/03/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
BrightPath Biotherapeutics Co., Ltd.
 BrightPath Biotherapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Provides research, development, production, and sale of cancer immunotherapies | Health Technology |
KORTUC, Inc.
KORTUC, Inc. Medical SpecialtiesHealth Technology Develops sensitizers for radiotherapy | Health Technology |
Advanced.Immunotherapy Co., Ltd. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
